Descripción

Risk of bias assessment for included studies in the vitamin D supplementation systematic review, evaluating randomization, blinding, and outcome reporting quality.

Figure 2

Chart

Source Paper

Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review.

Nutrients (2021)

PMID: 34684663

DOI: 10.3390/nu13103662

Cite This Figure

![Figure 2: Risk of bias assessment for included studies in the vitamin D supplementation systematic review, evaluating randomization, blinding, and outcome reporting quality.]()

> Source: Dominika Głąbska et al. "Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and I." *Nutrients*, 2021. PMID: [34684663](https://pubmed.ncbi.nlm.nih.gov/34684663/)

<figure>
  <img src="" alt="Risk of bias assessment for included studies in the vitamin D supplementation systematic review, evaluating randomization, blinding, and outcome reporting quality." />
  <figcaption>Figure 2. Risk of bias assessment for included studies in the vitamin D supplementation systematic review, evaluating randomization, blinding, and outcome reporting quality.<br>  Source: Dominika Głąbska et al. "Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and I." <em>Nutrients</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34684663/">34684663</a></figcaption>
</figure>

Evidencia relacionada

Vitamin D para Inflammatory Bowel Disease (IBD) — General

Calificación B · 10 estudios

Vitamin D para Irritable Bowel Syndrome (IBS)

Calificación C · 3 estudios